Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-12-17

FDA Approved: NEBIVOLOL — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved Nebivolol via an original Abbreviated New Drug Application by Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nebivolol (Nebivolol)

Snippet

ORIG AP for NEBIVOLOL (NEBIVOLOL)